Gallagher CM, Goodman MS. Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997–2002. J Toxicol Environ Health A 2010;73(24):1665–1677.
Geier DA, Hooker BS, Kern JK, King PG, Sykes LK, Geier MR. A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder in the United States. Transl Neurodegener 2013;2(1):25.
LOL.
Here ya go - these are cohort studies of huge numbers of children:
http://www.nejm.org/doi/full/10.1056/NEJMoa021134
RESULTS
Of the 537,303 children in the cohort (representing 2,129,864 person-years), 440,655 (82.0 percent) had received the MMR vaccine. We identified 316 children with a diagnosis of autistic disorder and 422 with a diagnosis of other autistic-spectrum disorders. After adjustment for potential confounders, the relative risk of autistic disorder in the group of vaccinated children, as compared with the unvaccinated group, was 0.92 (95 percent confidence interval, 0.68 to 1.24), and the relative risk of another autistic-spectrum disorder was 0.83 (95 percent confidence interval, 0.65 to 1.07).
There was no association between the age at the time of vaccination, the time since vaccination, or the date of vaccination and the development of autistic disorder.
http://putchildrenfirst.org/media/5.5.pdf
Phase I screened for associations between neurodevelopmental disorders and thimerosal exposure among 124 170 infants who were born during 1992 to 1999 at 2 HMOs (A and B).
Results
In phase I at HMO A, cumulative exposure at 3 months resulted in a significant positive association with tics (relative risk [RR]: 1.89; 95% confidence interval [CI]: 1.05–3.38). At HMO B, increased risks of language delay were found for cumulative exposure at 3 months (RR: 1.13; 95% CI: 1.01–1.27) and 7 months (RR: 1.07; 95% CI: 1.01–1.13). In phase II at HMO C, no significant associations were found.
In no analyses were significant increased risks found for autism or attention-deficit disorder.
https://www.researchgate.net/public...Kingdom_Does_Not_Support_a_Causal_Association
Results
Only in 1 analysis for tics was there some evidence of a higher risk with increasing doses (Cox’s HR: 1.50 per dose at 4 months; 95% confidence interval [CI]: 1.02–2.20). Statistically significant negative associations with increasing doses at 4 months were found for general developmental disorders (HR: 0.87; 95% CI: 0.81–0.93), unspecified developmental delay (HR: 0.80; 95% CI:0.69–0.92), and attention-deficit disorder (HR: 0.79; 95% CI: 0.64–0.98).
For the other disorders, there was no evidence of an association with thimerosal exposure.
http://jama.jamanetwork.com/data/Journals/JAMA/933762/JOI150033supp1_prod.pdf
Results Of 95 727 children with older siblings, 994 (1.04%) were diagnosed with ASD and 1929 (2.02%) had an older sibling with ASD. Of those with older siblings with ASD, 134 (6.9%) had ASD, vs 860 (0.9%) children with unaffected siblings (
P < .001). MMR vaccination rates (≥1 dose) were 84% (n = 78 549) at age 2 years and 92% (n = 86 063) at age 5 years for children with unaffected older siblings, vs 73% (n = 1409) at age 2 years and 86% (n = 1660) at age 5 years for children with affected siblings. MMR vaccine receipt was not associated with an increased risk of ASD at any age. For children with older siblings with ASD, at age 2, the adjusted relative risk (RR) of ASD for 1 dose of MMR vaccine vs no vaccine was 0.76 (95% CI, 0.48-1.22;
P = .25), and at age 5, the RR of ASD for 2 doses compared with no vaccine was 0.56 (95% CI, 0.30-1.04;
P = .07). For children whose older siblings did not have ASD, at age 2, the adjusted RR of ASD for 1 dose was 0.91 (95% CI, 0.68-1.20;
P = .50) and at age 5, the RR of ASD for 2 doses was 1.09 (95% CI, 0.76-1.54;
P = .65).
Conclusions and Relevance In this large sample of privately insured children with older siblings, receipt of the MMR vaccine was not associated with increased risk of ASD, regardless of whether older siblings had ASD.
These findings indicate no harmful association between MMR vaccine receipt and ASD even among children already at higher risk for ASD.
You have here FOUR direct cohort studies involving nearly a million children. Let that number sink in. Not 33...not 500...not 1,000...but over 850,000. Not one of those studies could find any link between vaccinations and autism. So move the goalposts and now claim it's aluminum. And when that's debunked, I'm sure you'll have something else.